Inventor · disambiguated record
Mark J. Graham
Also filed as: GRAHAM MARK · GRAHAM MARK J
67 granted patents·60 pending applications·1,970 citations·filing 1998–2025
99Inventor score
Files withISIS PHARMACEUTICALS INC45IONIS PHARMACEUTICALS INC37CROOKE ROSANNE M14GENZYME CORP7BENNETT C F3
Top patents by PatentIndex Score
127 records- 0199US7741305B2Modulation of apolipoprotein (a) expressionISIS PHARMACEUTICALS INC·Filed 2007·Granted Jun 22, 2010·135 cites·27 claims
- 0298US9181550B2Compositions and methods for modulating apolipoprotein (a) expressionISIS PHARMACEUTICALS INC·Filed 2014·Granted Nov 10, 2015·16 cites·26 claims
- 0398US9163239B2Compositions and methods for modulating apolipoprotein C-III expressionISIS PHARMACEUTICALS INC·Filed 2014·Granted Oct 20, 2015·20 cites·26 claims
- 0498US7723508B2Modulation of apolipoprotein (A) expressionISIS PHARMACEUTICALS INC·Filed 2004·Granted May 25, 2010·136 cites·24 claims
- 0598US7598227B2Modulation of apolipoprotein C-III expressionISIS PHARMACEUTICALS INC·Filed 2003·Granted Oct 6, 2009·292 cites·28 claims
- 0698US7425545B2Modulation of C-reactive protein expressionISIS PHARMACEUTICALS INC·Filed 2004·Granted Sep 16, 2008·158 cites·42 claims
- 0797US11851655B2Compositions and methods for modulating apolipoprotein (a) expressionIONIS PHARMACEUTICALS INC·Filed 2020·Granted Dec 26, 2023·3 cites·33 claims
- 0897US9957504B2Compositions and methods for modulating apolipoprotein (a) expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted May 1, 2018·8 cites·56 claims
- 0997US8093222B2Methods for treating hypercholesterolemiaFREIER SUSAN M·Filed 2009·Granted Jan 10, 2012·46 cites·68 claims
- 1097US7750141B2Modulation of apolipoprotein c-III expressionISIS PHARMACEUTICALS INC·Filed 2004·Granted Jul 6, 2010·64 cites·18 claims
- 1197US7335764B2Antisense modulation of acyl CoA cholesterol acyltransferase-2 expressionISIS PHARMACEUTICALS INC·Filed 2007·Granted Feb 26, 2008·119 cites·25 claims
- 1296US10883104B2Compositions and methods for modulating apolipoprotein (a) expressionIONIS PHARMACEUTICALS INC·Filed 2018·Granted Jan 5, 2021·5 cites·6 claims
- 1396US9932581B2Compositions and methods for modulating apolipoprotein C-III expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted Apr 3, 2018·6 cites·50 claims
- 1496US8673632B2Modulation of apolipoprotein (a) expressionCROOKE ROSANNE M·Filed 2010·Granted Mar 18, 2014·27 cites·4 claims
- 1596US8138328B2Modulation of apolipoprotein (A) expressionCROOKE ROSANNE M·Filed 2010·Granted Mar 20, 2012·30 cites·18 claims
- 1696US7407943B2Antisense modulation of apolipoprotein B expressionISIS PHARMACEUTICALS INC·Filed 2002·Granted Aug 5, 2008·61 cites·65 claims
- 1796US7259150B2Modulation of apolipoprotein (a) expressionISIS PHARMACEUTICALS INC·Filed 2003·Granted Aug 21, 2007·48 cites·26 claims
- 1896US7202357B2Antisense modulation of acyl CoA cholesterol acyltransferase-2 expressionISIS PHARMACEUTICALS INC·Filed 2002·Granted Apr 10, 2007·118 cites·18 claims
- 1995US8859514B2Modulation of C-reactive protein expressionCROOKE ROSANNE M·Filed 2010·Granted Oct 14, 2014·28 cites·25 claims
- 2095US8084437B2Methods for treating hypercholesterolemiaFREIER SUSAN M·Filed 2007·Granted Dec 27, 2011·44 cites·19 claims
- 2195US7803930B2Antisense modulation of apolipoprotein B-expressionISIS PHARMACEUTICALS INC·Filed 2004·Granted Sep 28, 2010·40 cites·36 claims
- 2295US7511131B2Antisense modulation of apolipoprotein B expressionGENZYME CORP·Filed 2003·Granted Mar 31, 2009·169 cites·57 claims
- 2394US12509684B2Compositions and methods for modulating apolipoprotein C-III expressionIONIS PHARMACEUTICALS INC·Filed 2024·Granted Dec 30, 2025·0 cites·20 claims
- 2494US9957292B2Compositions and methods for modulating angiopoietin-like 3 expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted May 1, 2018·11 cites·81 claims
- 2594US9382540B2Compositions and methods for modulating angiopoietin-like 3 expressionISIS PHARMACEUTICALS INC·Filed 2015·Granted Jul 5, 2016·13 cites·28 claims
- 2694US8653047B2Modulation of angiopoietin-like 3 expressionCROOKE ROSANNE M·Filed 2011·Granted Feb 18, 2014·18 cites·17 claims
- 2794US7863252B2Modulation of C-reactive protein expressionISIS PHARMACEUTICALS INC·Filed 2008·Granted Jan 4, 2011·22 cites·45 claims
- 2893US12291709B2Compositions and methods for modulating apolipoprotein (a) expressionIONIS PHARMACEUTICALS INC·Filed 2023·Granted May 6, 2025·0 cites·16 claims
- 2993US8664190B2Methods for treating hypercholesterolemiaFREIER SUSAN M·Filed 2011·Granted Mar 4, 2014·17 cites·13 claims
- 3093US2025313843A1Methods for treating hypercholesterolemiaIONIS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3192US10927372B2Compositions and methods for modulating apolipoprotein C-III expressionIONIS PHARMACEUTICALS INC·Filed 2018·Granted Feb 23, 2021·2 cites·34 claims
- 3292US8530439B2Modulation of apolipoprotein C-III expressionCROOKE ROSANNE M·Filed 2010·Granted Sep 10, 2013·13 cites·48 claims
- 3392US7888324B2Antisense modulation of apolipoprotein B expressionGENZYME CORP·Filed 2001·Granted Feb 15, 2011·30 cites·20 claims
- 3492US7227014B2Antisense modulation of apolipoprotein (a) expressionISIS PHARMACEUTICALS INC·Filed 2001·Granted Jun 5, 2007·26 cites·25 claims
- 3592US6184212B1Antisense modulation of human mdm2 expressionISIS PHARMACEUTICALS INC·Filed 1999·Granted Feb 6, 2001·78 cites·20 claims
- 3691US10858657B2Methods for treating hypercholesterolemiaIONIS PHARMACEUTICALS INC·Filed 2018·Granted Dec 8, 2020·2 cites·18 claims
- 3791US7491815B2Antisense modulation of C-reactive protein expressionISIS PHARMACEUTICALS INC·Filed 2005·Granted Feb 17, 2009·10 cites·48 claims
- 3891US6964950B2Antisense modulation of C-reactive protein expressionISIS PHARMACEUTICALS INC·Filed 2001·Granted Nov 15, 2005·26 cites·37 claims
- 3991US6767739B2Antisense modulation of microsomal triglyceride transfer protein expressionISIS PHARMACEUTICALS INC·Filed 2001·Granted Jul 27, 2004·22 cites·13 claims
- 4088US11530410B2Methods for treating hypercholesterolemiaIONIS PHARMACEUTICALS INC·Filed 2020·Granted Dec 20, 2022·1 cites·12 claims
- 4188US10912792B2Compounds and methods for modulating angiotensinogen expressionIONIS PHARMACEUTICALS INC·Filed 2016·Granted Feb 9, 2021·4 cites·11 claims
- 4287US10875884B2Compositions and methods for modulating angiopoietin-like 3 expressionIONIS PHARMACEUTICALS INC·Filed 2018·Granted Dec 29, 2020·4 cites·22 claims
- 4387US9650636B2Methods for treating hypercholesterolemiaISIS PHARMACEUTICALS INC·Filed 2014·Granted May 16, 2017·5 cites·20 claims
- 4487US7960358B2Antisense modulation of stearoyl-CoA desaturase expressionISIS PHARMACEUTICALS INC·Filed 2006·Granted Jun 14, 2011·3 cites·17 claims
- 4586US11634711B2Methods and compositions for modulating apolipoprotein (a) expressionIONIS PHARMACEUTICALS INC·Filed 2020·Granted Apr 25, 2023·1 cites·20 claims
- 4686US9624496B2Modulation of apolipoprotein C-III expressionIONIS PHARMACEUTICALS INC·Filed 2016·Granted Apr 18, 2017·3 cites·22 claims
- 4785US9574193B2Methods and compositions for modulating apolipoprotein (a) expressionIONIS PHARMACEUTICALS INC·Filed 2014·Granted Feb 21, 2017·2 cites·25 claims
- 4885US8912160B2Methods for treating hypercholesterolemiaISIS PHARMACEUTICALS INC·Filed 2014·Granted Dec 16, 2014·4 cites·13 claims
- 4985US7414033B2Modulation of diacylglycerol acyltransferase 1 expressionISIS PHARMACEUTICALS INC·Filed 2004·Granted Aug 19, 2008·8 cites·65 claims
- 5085US7132529B2Antisense modulation of stearoyl-CoA desaturase expressionISIS PHARMACEUTICALS INC·Filed 2001·Granted Nov 7, 2006·12 cites·10 claims
Showing the top 50 of 127 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Mark J. Graham files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →